Feb 15, 2024, 08:45 AM by

HEPA-10X mitigates the spread of infection in high-risk healthcare environments

Feb 15, 2024, 08:45 AM by

Optibrium today announced the release of StarDrop 7.6, the latest version of its platform for small molecule design, optimisation and analysis. As part of the release, Optibrium introduces a new extension, Idea Tracker, with which medicinal chemists can now easily trace molecular design and optimisation decisions through every step of the complex discovery process, from idea conception to selecting candidates for synthesis.

Feb 15, 2024, 08:45 AM by

New Thermo Scientific Dionex Inuvion Ion Chromatography System streamlines ion analysis and expands analytical testing capabilities for ionic and small polar compounds

Feb 15, 2024, 08:45 AM by

PrecisionLife and Metrodora Institute are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren's syndrome, and many more.

Feb 15, 2024, 08:37 AM by User Not Found

Bio-IT World | Researchers at University of California San Diego School of Medicine have found that the rules of vaccinology need to be reversed for Staphylococcus aureus (SA), the common and sometimes dangerous bacteria that humans encounter shortly after birth and are continuously exposed to for the remainder of their life.

Feb 14, 2024, 09:04 AM by

Alzheimer’s Research & Therapy: Linus Health Digital Clock and Recall Test Detects Early Cognitive Impairment in Over 80% of Patients Who Were Misclassified in Commonly Used Paper-Based Test

Feb 14, 2024, 09:04 AM by

Personalized Health Basel and Leading Life Sciences Organization Collaborate with MDClone to Drive Innovation

Feb 14, 2024, 00:00 AM by User Not Found

Bio-IT World | Researchers in California have shown that breast cancer patients with RNA expression levels of ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) in the bottom 50th percentile can confidently be treated with Keytruda (pembrolizumab) as well as surgery. Their cancer would have a zero percent chance of metastasizing in seven years.

Feb 13, 2024, 11:15 AM by

In 2022, the latest data from the International Agency for Research on Cancer's Global Cancer Observatory indicates that ten specific types of cancer collectively represented approximately two-thirds of both new cases and fatalities worldwide. Covering 185 countries and 36 different types of cancer, the rising demand for biologics, including monoclonal antibodies and immunotherapies, has surged due to the increasing incidence of cancer. These innovative treatments are revolutionizing cancer care by enhancing survival rates and minimizing adverse effects.

Feb 13, 2024, 11:15 AM by

Domainex, a leading drug discovery and integrated medicines research partner based in Cambridge UK, opens a new Biology Centre of Excellence to further support collaborations with pharmaceutical and biotechnology companies, patient foundations and leading academic institutions globally.

Feb 13, 2024, 01:00 AM by User Not Found

Bio-IT World | Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health have created a next-generation sequencing (NGS) technology that employs oligonucleotides (oligos)—short single strands of synthetic DNA—as bait for relevant targets of detection.

Feb 9, 2024, 09:16 AM by

BioTeam, Inc. has been awarded a contract by the National Human Genome Research Institute (NHGRI) to enhance its data ecosystem, accelerating genomic discoveries and improving human health outcomes.

Feb 9, 2024, 09:16 AM by

Feb 9, 2024, 09:16 AM by

Abzena launches LabZient™, an analytical platform accelerating antibody development timelines by combining predictive in-silico evaluation with laboratory methods. LabZient™ streamlines assessment, reduces costs, and enables early measurement of critical quality attributes. Fit-for-purpose across various antibody types, including mAbs and ADCs, LabZient™ enhances efficiency in biopharma development.

Feb 9, 2024, 01:00 AM by User Not Found

Bio-IT World | In biopharma R&D there is growing momentum around the use of Generative AI, the deep-learning algorithms capable of distilling complex knowledge into easily digestible summaries. But so far companies have been relatively modest in their ambitions for the technology.

Feb 8, 2024, 08:17 AM by

Visit booth 70 at Rocky Mountain ISPE Vendor Show and booth 943 at ISPE CaSA Annual Tech Show to meet Watson-Marlow engineers and discuss the company’s expert fluid path solutions

Feb 8, 2024, 08:17 AM by

Today ZeOmega, a population health management company, was named Best in KLAS for Payer Care Management Solutions for the third consecutive year. The newly released 2024 Best in KLAS: Software & Services Report recognized ZeOmega as a leader in its market category. This designation follows a record growth year in 2023 that included: 94% client retention, 16% client base expansion New tech partners (such as Microsoft) to enhance automation capabilities Product innovations and AI implementations that address care quality, utilization management, member engagement, and risk adjustment

Feb 8, 2024, 08:17 AM by

Feb 8, 2024, 08:17 AM by

Cotiviti announced they won 2024 Best in KLAS: Software & Services for its Quality Intelligence solution, which enables health plans to track, monitor, and improve quality compliance. With top feedback from its clients and other healthcare executives, Cotiviti earned the highest ratings in five of KLAS’s Customer Experience Pillars.

Feb 8, 2024, 08:17 AM by

Devens, MA, US / 30th January 2023 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS), a leader in peristaltic pumps and associated fluid path technologies, will showcase its diverse product range specially designed for medical devices and diagnostic instruments at MD&M West in Anaheim, CA, from February 6-8.